Study of LY2835219 for Mantle Cell Lymphoma

Clinical trial NCT01739309 · COMPLETED

Trial details

NCT number: NCT01739309
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2013-03-20
Primary completion: 2015-09-28
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.